Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). TFBS Bioscience's share price for the quarter that ended in Dec. 2025 was NT$20.9. TFBS Bioscience's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 35.0 Mil. Therefore, TFBS Bioscience's market cap for the quarter that ended in Dec. 2025 was NT$731.9 Mil.
TFBS Bioscience's quarterly market cap
declined
from Dec. 2024 (NT$991.8 Mil) to Jun. 2025 (NT$791.4 Mil) and
declined
from Jun. 2025 (NT$791.4 Mil) to Dec. 2025 (NT$731.9 Mil).
TFBS Bioscience's annual market cap
declined
from Dec. 2023 (NT$1,586.7 Mil) to Dec. 2024 (NT$991.8 Mil) and
declined
from Dec. 2024 (NT$991.8 Mil) to Dec. 2025 (NT$731.9 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. TFBS Bioscience's Enterprise Value for Today is NT$505.6 Mil.
TFBS Bioscience (ROCO:6939) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
TFBS Bioscience Market Cap Related Terms
TFBS Bioscience Market Cap Historical Data
* Premium members only.
The historical data trend for TFBS Bioscience's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6939 vs TMO, DHR, IDXX: Market Cap Comparison
For the Diagnostics & Research subindustry, TFBS Bioscience's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
TFBS Bioscience Market Cap vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, TFBS Bioscience's Market Cap distribution charts can be found below:
* The bar in red indicates where TFBS Bioscience's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
TFBS Bioscience's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TFBS Bioscience (ROCO:6939) has a Market Cap of NT$721.4 Mil as of Jul. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TFBS Bioscience and its competitors. According to the industry distribution chart, TFBS Bioscience ranks #148 out of 218 companies in the Medical Diagnostics & Research industry, placing it in the top 67.9%.
Is TFBS Bioscience's Market Cap too high?
TFBS Bioscience's current Market Cap is NT$721.4 Mil. Based on the distribution chart, TFBS Bioscience ranks #148 out of 218 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, TFBS Bioscience has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does TFBS Bioscience's Market Cap compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, TFBS Bioscience ranks #148 out of 218 companies for Market Cap. This places TFBS Bioscience in the lower half of its industry. The industry median Market Cap is 58.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Diagnostics & Research company?
The median Market Cap among Medical Diagnostics & Research companies is 58.80, based on 218 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on TFBS Bioscience and its competitors. For the Medical Diagnostics & Research industry, the median Market Cap is 58.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. TFBS Bioscience's current Market Cap is NT$721.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is TFBS Bioscience stock overvalued right now?
Based on GuruFocus' analysis, TFBS Bioscience (ROCO:6939) is currently considered Possible Value Trap. The stock's GF Value™ is NT$32.17, compared to a current price of NT$20.60 — trading 36% below its estimated fair value. The current Market Cap is NT$721.4 Mil. TFBS Bioscience's overall GF Score™ is 49/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For TFBS Bioscience (ROCO:6939), the current Market Cap is NT$721.4 Mil as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is TFBS Bioscience (ROCO:6939) Overvalued in 2026?
Based on GuruFocus' analysis, TFBS Bioscience stock appears to be undervalued.
The current stock price of NT$20.60 is trading 36% below its estimated GF Value™ of NT$32.17.
GuruFocus considers TFBS Bioscience to be Possible Value Trap.
Key valuation signals for ROCO:6939:
Market Cap: NT$721.4 Mil
GF Value™: NT$32.17 vs. price of NT$20.60 (36% below fair value)
No single metric tells the full story. See the ROCO:6939 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.
49GF Score
Get the complete analysis for ROCO:6939
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6939 has been successfully added to your 
